RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      KCI등재후보 SCOPUS

      당뇨발의 예방과 치료 = Prevention and management of the diabetic foot

      한글로보기

      https://www.riss.kr/link?id=A104782622

      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      다국어 초록 (Multilingual Abstract)

      In the diabetic foot, ulceration and amputation are the most serious causes of morbidity and disability in these patients. Peripheral arterial sclerosis, peripheral neuropathy, and foot deformities are major causes of foot problems. Foot deformities caused by autonomic and motor neuropathy lead, in turn, to over-pressured focal lesions causing the diabetic foot to be easily injured within the shoe while walking. Wound healing can be difficult in these patients because of impaired phagocytic activity by hyperglycemia, impaired migration of leukocytes due to a thickened basement membrane, malnutrition, and ischemia. Deformity correction or shoe modification to relieve the pressure of over-pressured points is necessary for ulcer management. Selective dressings allowing a moist environment following complete debridement of the necrotic tissue is mandatory. In the case of a large soft tissue defect due to aggressive debridement, a wound coverage procedure is necessary by either a distant flap operation or a skin graft. Amputation can be necessary in the case of an intractable ischemic toe or a life-threatening infected limb. The amputation level should be kept at its minimum to allow patients to walk, with or without a prosthesis,post-amputation. A foot with Charcot’s joint should be stabilized and consolidated into a plantigrade foot. The bony prominence of a Charcot foot can be corrected by a bumpectomy for prevention of ulceration. The most effective management of the diabetic foot is ulcer prevention;measures include controlling blood sugar levels, controlling neuropathic pain, smoking cessation,stretching exercises, frequent inspection of the foot, and education on appropriate footwear. A multidisciplinary approach is also highly recommended for managing diabetic foot problems.
      번역하기

      In the diabetic foot, ulceration and amputation are the most serious causes of morbidity and disability in these patients. Peripheral arterial sclerosis, peripheral neuropathy, and foot deformities are major causes of foot problems. Foot deformities c...

      In the diabetic foot, ulceration and amputation are the most serious causes of morbidity and disability in these patients. Peripheral arterial sclerosis, peripheral neuropathy, and foot deformities are major causes of foot problems. Foot deformities caused by autonomic and motor neuropathy lead, in turn, to over-pressured focal lesions causing the diabetic foot to be easily injured within the shoe while walking. Wound healing can be difficult in these patients because of impaired phagocytic activity by hyperglycemia, impaired migration of leukocytes due to a thickened basement membrane, malnutrition, and ischemia. Deformity correction or shoe modification to relieve the pressure of over-pressured points is necessary for ulcer management. Selective dressings allowing a moist environment following complete debridement of the necrotic tissue is mandatory. In the case of a large soft tissue defect due to aggressive debridement, a wound coverage procedure is necessary by either a distant flap operation or a skin graft. Amputation can be necessary in the case of an intractable ischemic toe or a life-threatening infected limb. The amputation level should be kept at its minimum to allow patients to walk, with or without a prosthesis,post-amputation. A foot with Charcot’s joint should be stabilized and consolidated into a plantigrade foot. The bony prominence of a Charcot foot can be corrected by a bumpectomy for prevention of ulceration. The most effective management of the diabetic foot is ulcer prevention;measures include controlling blood sugar levels, controlling neuropathic pain, smoking cessation,stretching exercises, frequent inspection of the foot, and education on appropriate footwear. A multidisciplinary approach is also highly recommended for managing diabetic foot problems.

      더보기

      참고문헌 (Reference)

      1 김신곤, "특집/우리나라 당뇨병의 현황" 대한의사협회 51 (51): 791-798, 2008

      2 Mendonca DA, "Vacuum-assisted closure to aid wound healing in foot and ankle surgery" 26 : 761-766, 2005

      3 Mann RA, "Tibial sesamoid shaving for treatment of intractable plantar keratosis" 13 : 196-198, 1992

      4 김대중, "The Epidemiology of Diabetes in Korea" 대한당뇨병학회 35 (35): 303-308, 2011

      5 Coughlin MJ, "Surgery of the foot and ankle. 8th ed" Mosby 2006

      6 Pitocco D, "Six-month treatment with alen-dronate in acute Charcot neuroarthropathy: a randomized con-trolled trial" 28 : 1214-1215, 2005

      7 Apelqvist J, "Prognostic value of systolic ankle and toe blood pressure levels in outcome of diabetic foot ulcer" 12 : 373-378, 1989

      8 Lin SS, "Plantar forefoot ulceration with equinus deformity of the ankle in diabetic patients: the effect of tendo-Achilles lengthening and total contact casting" 19 : 465-475, 1996

      9 Bamberger DM, "Osteomyelitis in the feet of diabetic patients. Long-term results, prognostic fac-tors, and the role of antimicrobial and surgical therapy" 83 : 653-660, 1987

      10 Park Y, "Management of the patients with diabetes mellitus and macro- and microvascular complications" 48 : 721-734, 2005

      1 김신곤, "특집/우리나라 당뇨병의 현황" 대한의사협회 51 (51): 791-798, 2008

      2 Mendonca DA, "Vacuum-assisted closure to aid wound healing in foot and ankle surgery" 26 : 761-766, 2005

      3 Mann RA, "Tibial sesamoid shaving for treatment of intractable plantar keratosis" 13 : 196-198, 1992

      4 김대중, "The Epidemiology of Diabetes in Korea" 대한당뇨병학회 35 (35): 303-308, 2011

      5 Coughlin MJ, "Surgery of the foot and ankle. 8th ed" Mosby 2006

      6 Pitocco D, "Six-month treatment with alen-dronate in acute Charcot neuroarthropathy: a randomized con-trolled trial" 28 : 1214-1215, 2005

      7 Apelqvist J, "Prognostic value of systolic ankle and toe blood pressure levels in outcome of diabetic foot ulcer" 12 : 373-378, 1989

      8 Lin SS, "Plantar forefoot ulceration with equinus deformity of the ankle in diabetic patients: the effect of tendo-Achilles lengthening and total contact casting" 19 : 465-475, 1996

      9 Bamberger DM, "Osteomyelitis in the feet of diabetic patients. Long-term results, prognostic fac-tors, and the role of antimicrobial and surgical therapy" 83 : 653-660, 1987

      10 Park Y, "Management of the patients with diabetes mellitus and macro- and microvascular complications" 48 : 721-734, 2005

      11 Prosdocimi M, "Impaired wound healing in dia-betes: the rationale for clinical use of hyaluronic acid plus silver sulfadiazine" 103 : 533-539, 2012

      12 Valenzuela-Silva CM, "Granulation response and par-tial wound closure predict healing in clinical trials on advanced diabetes foot ulcers treated with recombinant human epidermal growth factor" 36 : 210-215, 2013

      13 Zimmet P, "Global and societal implications of the diabetes epidemic" 414 : 782-787, 2001

      14 Oh TS, "Diabetic foot reconstruction using free flaps increases 5-year-survival rate" 66 : 243-250, 2013

      15 Wheat LJ, "Diabetic foot infections: bacteriologic analysis" 146 : 1935-1940, 1986

      16 Kim KW, "Diabetic foot" 50 : 447-454, 2007

      17 Beckman JA, "Diabetes and atheroscle-rosis: epidemiology, pathophysiology, and management" 287 : 2570-2581, 2002

      18 Donas KP, "Below knee bare nitinol stent placement in high-risk patients with critical limb ischemia is still durable after 24 months of follow-up" 52 : 356-361, 2010

      19 Kim JM, "A clinical study on the diabetic foot lesions" 17 : 387-394, 1993

      20 Kwon YJ, "A clinical study on the diabetic foot lesions" 13 : 39-46, 1989

      21 Wagner FW, "A classification and treatment program for diabe-tic, neuropathic, and dysvascular foot problems" 28 : 143-165, 1979

      더보기

      동일학술지(권/호) 다른 논문

      동일학술지 더보기

      더보기

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      인용정보 인용지수 설명보기

      학술지 이력

      학술지 이력
      연월일 이력구분 이력상세 등재구분
      2024 평가예정 해외DB학술지평가 신청대상 (해외등재 학술지 평가)
      2021-01-01 평가 등재학술지 선정 (해외등재 학술지 평가) KCI등재
      2020-12-01 평가 등재 탈락 (해외등재 학술지 평가)
      2013-10-01 평가 등재학술지 선정 (기타) KCI등재
      2011-01-01 평가 등재후보학술지 유지 (기타) KCI등재후보
      2007-01-01 평가 SCOPUS 등재 (신규평가) KCI등재후보
      더보기

      학술지 인용정보

      학술지 인용정보
      기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
      2016 0.33 0.33 0.48
      KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
      0.5 0.57 0.815 0.12
      더보기

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼